Ex-Div Reminder for Calamos Global Dynamic Income Fund (CHW)

Looking at the universe of stocks we cover at Dividend Channel, on 2/7/14, Calamos Global Dynamic Income Fund (CHW) will trade ex-dividend, for its monthly dividend of $0.062, payable on 2/14/14. As a percentage of CHW's recent stock price of $8.68, this dividend works out to approximately 0.71%, so look for shares of Calamos Global Dynamic Income Fund to trade 0.71% lower — all else being equal — when CHW shares open for trading on 2/7/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CHW, showing historical dividends prior to the most recent $0.062 declared by Calamos Global Dynamic Income Fund:

CHW+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CHW is likely to continue, and whether the current estimated yield of 8.57% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of CHW shares, versus its 200 day moving average:

Calamos Global Dynamic Income Fund 200 Day Moving Average Chart

Looking at the chart above, CHW's low point in its 52 week range is $7.97 per share, with $9.25 as the 52 week high point — that compares with a last trade of $8.68.

In Wednesday trading, Calamos Global Dynamic Income Fund shares are currently up about 0.1% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says